TY  - GEN
AU  - Villanueva-Paz, Marina
AU  - Niu, Hao
AU  - Segovia-Zafra, Antonio
AU  - Medina-Caliz, Inmaculada
AU  - Sanabria-Cabrera, Judith
AU  - Lucena, M. Isabel
AU  - Andrade, Raul J.
AU  - Alvarez-Alvarez, Ismael
PY  - 2021
DO  - 10.3390/jcm10225317
UR  - https://hdl.handle.net/10668/26977
T2  - Journal of clinical medicine
AB  - Drug-induced liver injury (DILI) encompasses the unexpected damage that drugs can cause to the liver. DILI may develop in the context of an immunoallergic syndrome with cutaneous manifestations, which are sometimes severe (SCARs). Nevirapine,...
LA  - en
PB  - Mdpi
KW  - drug-induced liver injury
KW  - severe cutaneous adverse reactions
KW  - hypersensitivity
KW  - gaps
KW  - causality assessment
KW  - diagnosis
KW  - management
KW  - clinical trial
KW  - immune response
KW  - Toxic epidermal necrolysis
KW  - Stevens-johnson syndrome
KW  - Systemic symptoms dress
KW  - Induced hypersensitivity reactions
KW  - Lymphocyte-transformation test
KW  - Causality assessment methods
KW  - Clinical-features
KW  - Idiosyncratic hepatotoxicity
KW  - Intravenous immunoglobulin
KW  - Immunomodulating therapies
TI  - Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
TY  - review
VL  - 10
ER  -